Home » Cephalon Completes Acquisition of Salmedix
Cephalon Completes Acquisition of Salmedix
June 27, 2005
Cephalon announced that it has completed its previously announced acquisition of all of the outstanding capital stock of Salmedix. As a result of the acquisition, Salmedix is now a wholly-owned subsidiary of Cephalon. Cephalon will update 2005 guidance to reflect the impact, if any, of the Salmedix acquisition, the Company's previously announced tender offer for its 2-1/2 percent convertible notes and certain other transactions, when it releases second quarter earnings in early August.
BioSpace (http://www.biospace.com/news_story.cfm?StoryID=20360120&full=1)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct